Easton Pharmaceutica Valuation
| EAPH Stock | USD 0.0001 0.00 0.00% |
Easton Pharmaceutica seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Easton Pharmaceutica from reviewing the firm fundamentals such as Gross Profit of 201.4 K, current valuation of 2.14 M, and Price To Earning of (22.00) X as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Easton Pharmaceutica's valuation include:
Price Book 0.002 | Enterprise Value | Enterprise Value Ebitda (11.26) | Price Sales 0.064 | Enterprise Value Revenue 5.6431 |
Overvalued
Today
Please note that Easton Pharmaceutica's price fluctuation is very steady at this time. Calculation of the real value of Easton Pharmaceutica is based on 3 months time horizon. Increasing Easton Pharmaceutica's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Easton Pharmaceutica is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Easton Stock. However, Easton Pharmaceutica's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Easton Pharmaceutica's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Easton Pharmaceutica's stock price.
Estimating the potential upside or downside of Easton Pharmaceutica helps investors to forecast how Easton stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Easton Pharmaceutica more accurately as focusing exclusively on Easton Pharmaceutica's fundamentals will not take into account other important factors: When choosing an evaluation method for Easton Pharmaceutica, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Easton Pharmaceutica Cash |
|
Easton Valuation Drivers Correlation
Many accounts on the financial statements of Easton Pharmaceutica are highly interrelated and sometimes correlated. Consequently, when conducting Easton's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Easton
Click cells to compare fundamentals
Easton Valuation Trend
Easton Pharmaceutica's real value analysis enables investors to forecast the earnings more efficiently. Using both Easton Pharmaceutica's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
Easton Pharmaceutica Total Value Analysis
Easton Pharmaceutica is currently projected to have valuation of 2.14 M with market capitalization of 134.49 K, debt of 3.28 M, and cash on hands of 5.81 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Easton Pharmaceutica fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.14 M | 134.49 K | 3.28 M | 5.81 K |
Easton Pharmaceutica Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Easton signifies not a very effective usage of assets in March.Easton Pharmaceutica Profitability Analysis
Net Loss for the year was (188.54 K) with profit before overhead, payroll, taxes, and interest of 201.4 K.About Easton Pharmaceutica Valuation
An absolute valuation paradigm, as applied to Easton Stock, attempts to find the value of Easton Pharmaceutica based on its fundamental and basic technical indicators. By analyzing Easton Pharmaceutica's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Easton Pharmaceutica's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Easton Pharmaceutica. We calculate exposure to Easton Pharmaceutica's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Easton Pharmaceutica's related companies.| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (0.19) | (0.20) | |
| Operating Profit Margin | (0.19) | (0.20) | |
| Net Loss | (0.19) | (0.20) | |
| Gross Profit Margin | 0.15 | 0.14 |
Easton Pharmaceutica Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 1.3 B | |
| Shares Float | 1.3 B |
Easton Pharmaceutica Current Valuation Indicators
Valuation refers to the process of determining the present value of Easton Pharmaceutica and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Easton we look at many different elements of the entity such as Easton's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Easton Pharmaceutica, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Easton Pharmaceutica's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Easton Pharmaceutica's worth.Complementary Tools for Easton Stock analysis
When running Easton Pharmaceutica's price analysis, check to measure Easton Pharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Easton Pharmaceutica is operating at the current time. Most of Easton Pharmaceutica's value examination focuses on studying past and present price action to predict the probability of Easton Pharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Easton Pharmaceutica's price. Additionally, you may evaluate how the addition of Easton Pharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |